GO
Loading...

Medtronic PLC

More

  • March 16- A minimally invasive procedure that allows doctors to implant a new heart valve supplying blood to the body is safe for low-risk patients, according to a study presented at the American College of Cardiology meeting in San Diego. Samir Kapadia, a cardiologist at the Cleveland Clinic in Ohio. The results presented Sunday are of particular interest for...

  • BUSINESS-NEWS-SCHEDULE AT 2000 GMT / 4 PM ET Sunday, 15 Mar 2015 | 4:23 PM ET

    March 15- Editor: Christian Plumb+ 1 646 223 6200. BUENOS AIRES- Argentina's economy may be stagnant but the capital city Buenos Aires is looking better than it has in years, boosting the popularity of its mayor as he prepares to run for president in October. LOS ANGELES- "Cinderella" enchants audiences this weekend, racking up a royal $70.1 million to lead the domestic...

  • March 15- Researchers on Sunday presented trial data showing very low mortality and stroke rates using the third generation version of Edwards Lifesciences Corp's non-invasive heart valve replacement system that could help support its U.S. approval. Data compiled 30 days after the procedure showed a 2.2 percent mortality rate in high risk patients and a...

  • March 15- Patients treated with Medtronic Plc's CoreValve non-invasive heart valve replacement system fared better two years after the procedure than those who underwent surgical valve replacement, according to data from a study presented on Sunday. The data not only showed that results seen at one year were sustained a year later, but that there were...

  • Feb 20- The U.S. Food and Drug Administration approved Medtronic Inc's device to permanently treat varicose veins on the legs. The VenaSeal closure system works by sealing the affected veins using an adhesive agent injected through a catheter. The device is manufactured by Covidien LLC, whose acquisition Medtronic completed last month.

  • Feb 20- The U.S. Food and Drug Administration said it approved Medtronic Inc's device to permanently treat varicose veins of the legs. The VenaSeal closure system works by sealing the affected superficial veins using an adhesive agent. The device is manufactured by Covidien LLC, whose acquisition Medtronic completed last month.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- The S&P 500 ended above 2,100 at another record high on Tuesday as optimism grew that a debt deal would be reached with Greece and as bond prices sold off. In a possible sign of progress for Greece, a source told Reuters the country intends to ask for an extension of a loan agreement Wednesday.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks inched higher on Tuesday, pushing the S&P 500 above 2,100 to another record intraday high as optimism grew that a debt deal would be reached with Greece. A source told Reuters that Greece intends to ask for an extension of a loan agreement tomorrow.

  • US STOCKS-Wall St flat, paring losses on Greece hopes Tuesday, 17 Feb 2015 | 12:49 PM ET

    *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks were flat on Tuesday, paring modest early losses and putting the S&P 500 back near record levels as optimism grew that a debt deal would be reached with Greece. A source told Reuters that Greece intends to ask for an extension of a loan agreement tomorrow.

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks edged lower on Tuesday, with the S&P 500 pulling back from record levels as investors continued to grapple with the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in Greece, as well as reduced tension between...

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stocks edged lower on Tuesday, with the S&P 500 pulling back from record levels as investors continued to grapple with the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in Greece, as well as reduced tension between...

  • *Investors watching situations in Greece, Ukraine. NEW YORK, Feb 17- U.S. stock index futures pointed to a quiet open on Tuesday, the first trading session after the S&P 500 closed at a record high, although investors continued to watch the uncertainty over a Greek debt deal and a fragile Ukraine truce. Much of the advance came on signs of progress for the debt deal in...

  • Early movers: HOT, MDT, WWW, WM, Z, AAPL & more Tuesday, 17 Feb 2015 | 8:28 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Feb 17- Medical device maker Medtronic Plc reported a better-than-expected quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. With sales of $2.22 billion in the third quarter ended Jan. 23, the business accounted for a little over half of overall sales. The company, which completed its acquisition of Ireland-...

  • Medtronic profit rises on higher cardiac device sales Tuesday, 17 Feb 2015 | 7:36 AM ET

    Feb 17- Medical device maker Medtronic Plc reported a 28 percent rise quarterly profit, helped mainly by increased sales in its cardiac and vascular business, its largest. The company, which completed its acquisition of Ireland- based Covidien Plc in January, said its net profit rose to $977 million, or 98 cents per share, for the third quarter ended Jan. 23, from $762...

  • Wall Street shaky as Greek debt talks collapse Tuesday, 17 Feb 2015 | 6:01 AM ET

    US stock index futures signaled a lower open on Tuesday, following Europe, after talks between Greece and its euro zone partners broke down.

  • After stroke, clot removal saves brain function - studies Wednesday, 11 Feb 2015 | 12:00 PM ET

    The two studies used devices made by Covidien, which was acquired by Medtronic PLC last month and helped pay for one of the trials. Stryker Corp and privately-held Penumbra Inc also manufacture devices approved for clot removal. Patrick Lyden, director of the Stroke Program at Cedars-Sinai Medical Center in Los Angeles, who was not involved in the studies.

  • Allergan Actavis

    M&A experts forecast there will be more major pharma deals in 2015 — but the U.K. won’t be a focus and the deals won’t be done for tax reasons.

  • Why one VC is investing, despite seeing a bubble Tuesday, 3 Feb 2015 | 11:07 AM ET
    Entrepreneur

    Joe Horowitz has been in venture capital for three decades, so he knows how to spot a bubble. Too many billion-dollar start-ups is a big sign.

  • Medtronic closes on Covidien deal: CEO   Tuesday, 27 Jan 2015 | 9:47 AM ET
    Medtronic closes on Covidien deal: CEO

    Omar Ishrak, Medtronic chairman and CEO, discusses the strategic plan behind its merger with Covidien and the headwinds caused by the strong U.S. dollar.